• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶体活性限制了γ干扰素刺激后MHC I类分子的组装。

Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.

作者信息

Benham A M, Neefjes J J

机构信息

Division Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam.

出版信息

J Immunol. 1997 Dec 15;159(12):5896-904.

PMID:9550386
Abstract

For an effective CD8+ cytotoxic T cell response to occur during infection, MHC class I molecules must be loaded with antigenic peptides in the endoplasmic reticulum. The cytosolic factor responsible for peptide generation is believed to be the proteasome, with the TAP heterodimer mediating peptide transport into the endoplasmic reticulum. However, the rate-determining step(s) in this intracellular pathway of Ag presentation is currently unresolved. The availability of a specific and irreversible proteasome inhibitor called lactacystin has enabled us to determine the amount of proteasomes required for the peptide loading of MHC class I molecules in four cell types. In the absence of the IFN-gamma-inducible proteasome subunits LMP2 and LMP7, the trypsin-like (but not the chymotrypsin-like) activity of the proteasome is directly related to MHC class I peptide loading. However, IFN-gamma stimulation or assimilation of catalytic LMP2 and LMP7 subunits into proteasomes causes both chymotrypsin- and trypsin-like activities of the proteasome to become limiting for the loading of class I molecules. Our data suggest that upon full IFN-gamma stimulation, peptide supply by the proteasome is the limiting step in the assembly of MHC class I polypeptides. This mechanism may enable the cell to prevent competition between novel Ags and the pool of endogenous proteins for binding to MHC class I molecules.

摘要

为了在感染期间产生有效的CD8+细胞毒性T细胞应答,MHC I类分子必须在内质网中加载抗原肽。负责肽生成的胞质因子被认为是蛋白酶体,TAP异二聚体介导肽向内质网的转运。然而,目前尚不清楚这种细胞内抗原呈递途径中的限速步骤。一种名为乳胞素的特异性不可逆蛋白酶体抑制剂的可用性,使我们能够确定四种细胞类型中MHC I类分子肽加载所需的蛋白酶体数量。在缺乏IFN-γ诱导的蛋白酶体亚基LMP2和LMP7的情况下,蛋白酶体的胰蛋白酶样(而非糜蛋白酶样)活性与MHC I类肽加载直接相关。然而,IFN-γ刺激或催化性LMP2和LMP7亚基融入蛋白酶体,会使蛋白酶体的糜蛋白酶样和胰蛋白酶样活性都成为I类分子加载的限制因素。我们的数据表明,在完全IFN-γ刺激下,蛋白酶体提供的肽是MHC I类多肽组装中的限速步骤。这种机制可能使细胞能够防止新抗原与内源性蛋白质库之间竞争与MHC I类分子结合。

相似文献

1
Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.蛋白酶体活性限制了γ干扰素刺激后MHC I类分子的组装。
J Immunol. 1997 Dec 15;159(12):5896-904.
2
MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.高效抗原呈递并不需要MHC编码的蛋白酶体亚基LMP2和LMP7。
J Immunol. 1994 Feb 1;152(3):1163-70.
3
Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.γ-干扰素与主要组织相容性复合体(MHC)基因的表达可调节蛋白酶体对肽的水解作用。
Nature. 1993 Sep 16;365(6443):264-7. doi: 10.1038/365264a0.
4
Allelic differences in the relationship between proteasome activity and MHC class I peptide loading.蛋白酶体活性与MHC I类肽负载之间关系的等位基因差异。
J Immunol. 1998 Jul 1;161(1):83-9.
5
Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.蛋白酶体亚基LMP2和LMP7缺陷细胞中受H-2Kb、Db或Kd限制的病毒抗原呈递
Eur J Immunol. 1994 Aug;24(8):1863-8. doi: 10.1002/eji.1830240822.
6
Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.新型二肽醛是蛋白酶体抑制剂,可阻断MHC-I抗原加工途径。
J Immunol. 1995 Aug 15;155(4):1767-75.
7
Incorporation of major histocompatibility complex--encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-gamma.主要组织相容性复合体编码的亚基LMP2和LMP7的掺入改变了20S蛋白酶体多肽加工产物的质量,且与γ干扰素无关。
Eur J Immunol. 1995 Sep;25(9):2605-11. doi: 10.1002/eji.1830250930.
8
IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.干扰素-γ暴露了HIV-1逆转录酶中一个隐藏的细胞毒性T淋巴细胞表位。
J Immunol. 1999 Jun 15;162(12):7075-9.
9
Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells.非经典MHC限制的CD8 + T细胞对共享的人类前列腺癌相关抗原的识别。
J Immunol. 1999 Dec 1;163(11):6330-7.
10
Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex.由主要组织相容性复合体编码的“20S”蛋白酶体(多催化蛋白酶)的亚基。
Nature. 1991 Oct 17;353(6345):662-4. doi: 10.1038/353662a0.

引用本文的文献

1
Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini.卡非佐米改变骨髓瘤细胞的HLA呈递肽组,并损害具有芳香族C末端的肽的呈递。
Blood Cancer J. 2016 Apr 8;6(4):e411. doi: 10.1038/bcj.2016.14.
2
Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I.卡非佐米增强自然杀伤细胞介导的骨髓瘤细胞裂解,这与人类白细胞抗原I类分子表达降低有关。
Oncotarget. 2015 Sep 29;6(29):26982-94. doi: 10.18632/oncotarget.4831.
3
Re-examining class-I presentation and the DRiP hypothesis.
重新审视I类呈递与DRiP假说。
Trends Immunol. 2014 Apr;35(4):144-52. doi: 10.1016/j.it.2014.01.002. Epub 2014 Feb 21.
4
Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells.人类白细胞抗原 E 有助于保护肿瘤细胞免受自然杀伤细胞的溶解。
Neoplasia. 2011 Sep;13(9):822-30. doi: 10.1593/neo.101684.
5
Unraveling molecular signatures of immunostimulatory adjuvants in the female genital tract through systems biology.通过系统生物学揭示女性生殖道中免疫刺激性佐剂的分子特征。
PLoS One. 2011;6(6):e20448. doi: 10.1371/journal.pone.0020448. Epub 2011 Jun 7.
6
Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma.硼替佐米下调HLA I类分子的细胞表面表达,并增强自然杀伤细胞介导的骨髓瘤细胞裂解作用。
Blood. 2008 Feb 1;111(3):1309-17. doi: 10.1182/blood-2007-03-078535. Epub 2007 Oct 18.
7
IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response.干扰素-γ诱导的蛋白酶体系统免疫适应性是一种加速的短暂反应。
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9241-6. doi: 10.1073/pnas.0501711102. Epub 2005 Jun 8.
8
PI31 is a modulator of proteasome formation and antigen processing.PI31是蛋白酶体形成和抗原加工的调节剂。
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14344-9. doi: 10.1073/pnas.212257299. Epub 2002 Oct 8.